While entirely speculative at this stage, enhanced uptake of vitamin B6, as well as altered levels and activation states of enzymes responsible for intracellular vitamer B6 conversion in cancer cells, could affect the levels of pyridoxal and PLP availability and propensity as MR1 ligands, which will be an exciting topic for further investigation. The gene discussed is MR1; the disease is cancer.